🇺🇸 Teriparatide (Forteo) in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abnormal Sensation In Eye — 1 report (10%)
  2. Arthropathy — 1 report (10%)
  3. Back Pain — 1 report (10%)
  4. Epistaxis — 1 report (10%)
  5. Erythema — 1 report (10%)
  6. Gait Disturbance — 1 report (10%)
  7. Genital Erythema — 1 report (10%)
  8. Headache — 1 report (10%)
  9. Hypoaesthesia — 1 report (10%)
  10. Increased Tendency To Bruise — 1 report (10%)

Source database →

Teriparatide (Forteo) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Teriparatide (Forteo) approved in United States?

Teriparatide (Forteo) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Teriparatide (Forteo) in United States?

M.D. Anderson Cancer Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.